Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 5.55 MB, PDF document
Reduced glomerular filtration rate (GFR) can progress to kidney failure. Risk factors include genetics and diabetes mellitus (DM), but little is known about their interaction. We conducted genome-wide association meta-analyses for estimated GFR based on serum creatinine (eGFR), separately for individuals with or without DM (nDM = 178,691, nnoDM = 1,296,113). Our genome-wide searches identified (i) seven eGFR loci with significant DM/noDM-difference, (ii) four additional novel loci with suggestive difference and (iii) 28 further novel loci (including CUBN) by allowing for potential difference. GWAS on eGFR among DM individuals identified 2 known and 27 potentially responsible loci for diabetic kidney disease. Gene prioritization highlighted 18 genes that may inform reno-protective drug development. We highlight the existence of DM-only and noDM-only effects, which can inform about the target group, if respective genes are advanced as drug targets. Largely shared effects suggest that most drug interventions to alter eGFR should be effective in DM and noDM.
Original language | English |
---|---|
Journal | Communications Biology |
Volume | 5 |
Pages (from-to) | 580 |
Number of pages | 20 |
ISSN | 2399-3642 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
© 2022. The Author(s).
- Creatinine, Diabetes Mellitus, Diabetic Nephropathies/genetics, Genome-Wide Association Study, Glomerular Filtration Rate/genetics, Humans, Kidney
Research areas
ID: 311338757